Utilidad de la difusión en los tumores óseos y de partes blandas. Correlación ADC-Hallazgos histológicos

Congress:

SERAM 2014

Poster Number:

S-1165

Type:

Comunicación Oral

Keywords:

Neoplasia, Treatment effects, MR-Spectroscopy, MR, Musculoskeletal soft tissue, Musculoskeletal bone

Authors:

J. Carrascoso Arranz¹, A. Acevedo¹, L. Herraiz Hidalgo¹, R. Cano Alonso², J. R. Larrubia Marfil³, V. Martinez de Vega²; ¹Pozuelo de Alarcón (Madrid)/ES, ²Madrid/ES, ³Guadalajara/ES

DOI:

10.1594/seram2014/S-1165

DOI-Link:

https://dx.doi.org/10.1594/seram2014/S-1165

Bibliografía

(1) Costa FM, Ferreira EC, Vianna EM. Diffusion-weighted magnetic resonance imaging for the evaluation of musculoskeletal tumors. Magn Reson Imaging Clin N Am 2011 Feb;19(1):159-80.

(2) Costa FM, Canella C, Gasparetto E. Advanced magnetic resonance imaging techniques in the evaluation of musculoskeletal tumors. Radiol Clin North Am 2011 Nov;49(6):1325-58.

(3) Bley TA, Wieben O, Uhl M. Diffusion-weighted MR imaging in musculoskeletal radiology: applications in trauma, tumors, and inflammation. Magn Reson Imaging Clin N Am 2009 May;17(2):263-75.

(4) Khoo MM, Tyler PA, Saifuddin A, Padhani AR. Diffusion-weighted imaging (DWI) in musculoskeletal MRI: a critical review. Skeletal Radiol 2011 Jun;40(6):665-81.

(5) Vilanova JC, Luna A, Baleato S, Romero MJ. Aplicaciones de la técnica de difusión por resonancia magnética en el manejo de la patología tumoral osteomuscular. Radiología 2012 Sep;54 (1):14-26.

(6) Baur A, Reiser MF. Diffusion-weighted imaging of the musculoskeletal system in humans. Skeletal Radiol 2000 Oct;29(10):555-62.

(7) Padhani AR, Koh DM. Diffusion MR imaging for monitoring of treatment response. Magn Reson Imaging Clin N Am 2011 Feb;19(1):181-209.

(8) Einarsdottir H, Karlsson M, Wejde J, Bauer HC. Diffusion-weighted MRI of soft tissue tumours. Eur Radiol 2004 Jun;14(6):959-63.

(9) Qi ZH, Li CF, Ma XX, Yang H, Jiang BD, Zhang K, et al. [Value of 3T magnetic resonance dynamic contrast-enhanced and diffusion-weighted imaging in differential diagnosis of musculoskeletal tumors]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2012 Apr;34(2):138-45.

(10) Khedr SA, Hassaan MA, Abdelrazek NM, Sakr AY. Diagnostic impact of echo planar diffusion-weighted magnetic resonance imaging (DWI) in musculoskeletal neoplastic masses using apparent diffusion coefficient (ADC) mapping as a quantitative assessment tool. The Egyptian Journal of Radiology and Nuclear Medicine 2012;43:219-26.

(11) Nagata S, Nishimura H, Uchida M, Sakoda J, Tonan T, Hiraoka K, et al. Diffusion-weighted imaging of soft tissue tumors: usefulness of the apparent diffusion coefficient for differential diagnosis. Radiat Med 2008 Jun;26(5):287-95.

(12) Neubauer H, Evangelista L, Hassold N, Winkler B, Schlegel PG, Kostler H, et al. Diffusion-weighted MRI for detection and differentiation of musculoskeletal tumorous and tumor-like lesions in pediatric patients. World J Pediatr 2012 Nov;8(4):342-9.

(13) De CT, Jans L, Sys G, Huysse W, Verstraeten T, Forsyth R, et al. Dynamic contrast-enhanced MR imaging for differentiation between enchondroma and chondrosarcoma. Eur Radiol 2013 Nov;23(11):3140-52.

(14) Geirnaerdt MJ, Hogendoorn PC, Bloem JL, Taminiau AH, van der Woude HJ. Cartilaginous tumors: fast contrast-enhanced MR imaging. Radiology 2000 Feb;214(2):539-46.

(15) Douis H, Saifuddin A. The imaging of cartilaginous bone tumours. I. Benign lesions. Skeletal Radiol 2012 Sep;41(10):1195-212.

(16) Nagata S, Nishimura H, Uchida M, Hayabuchi N. [Usefulness of diffusion-weighted MRI in differentiating benign from malignant musculoskeletal tumors]. Nihon Igaku Hoshasen Gakkai Zasshi 2005 Jan;65(1):30-6.

(17) Harish S, Chiavaras MM, Kotnis N, Rebello R. MR imaging of skeletal soft tissue infection: utility of diffusion-weighted imaging in detecting abscess formation. Skeletal Radiol 2011 Mar;40(3):285-94.

(18) Oka K, Yakushiji T, Sato H, Yorimitsu S, Hayashida Y, Yamashita Y, et al. Ability of diffusion-weighted imaging for the differential diagnosis between chronic expanding hematomas and malignant soft tissue tumors. J Magn Reson Imaging 2008 Nov;28(5):1195-200.

(19) Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009 Jan;45(2):228-47.

(20) Hayashida Y, Yakushiji T, Awai K, Katahira K, Nakayama Y, Shimomura O, et al. Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: Initial results. Eur Radiol 2006 Dec;16(12):2637-43.

(21) Uhl M, Saueressig U, van BM, Kontny U, Niemeyer C, Kohler G, et al. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging. Invest Radiol 2006 Aug;41(8):618-23.

(22) Bajpai J, Gamnagatti S, Kumar R, Sreenivas V, Sharma MC, Khan SA, et al. Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis. Pediatr Radiol 2011 Apr;41(4):441-50.

(23) Oka K, Yakushiji T, Sato H, Hirai T, Yamashita Y, Mizuta H. The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient. Skeletal Radiol 2010 Feb;39(2):141-6.

(24) Carrascoso Arranz, J; Acevedo A, Herraiz, L: Vilanova JR. Actualizaciones SERAM. Bases, conceptos técnicos y aplicaciones clínicas de la RM difusión. Capítulo 10. Difusión en musculoesquelético pag 109-120. 2012.